RENOVITE nanoclay providing unprecedented retention of biologics for tissue regeneration.
Renovos’ RENOVITE® nanoclay technology overcomes key efficacy and safety issues in regenerative medicine, by providing unprecedented retention of therapeutic agents (biologics, drugs, cells) localised at the target site of repair, until the material biodegrades and is replaced with newly regenerated tissue. This allows a significantly reduced dose, improved safety and cost.
Read more